Related Experiment Video
Updated: Apr 16, 2026

Quantification of Hypopigmentation Activity In Vitro
Published on: March 6, 2019
Kaempferol protects melanocytes from ferroptosis by modulating the NF-κB/PTGS2 signaling axis in vitiligo
Xuqing Xu1, Zixian Lei2,3,4, Wen Hu2,3,4
1Graduate School of Xinjiang Medical University, Urumqi, China.
Abstract:
Oxidative stress-induced ferroptosis is increasingly recognized as an important contributor to melanocyte destruction in vitiligo; however, the specific upstream signaling networks linking inflammatory signaling to ferroptosis susceptibility remain incompletely defined. Kaempferol, a natural flavonoid and key bioactive constituent of the traditional herb Vernonia anthelmintica (L.) Willd., possesses antioxidant and anti-inflammatory properties, yet its potential to mitigate melanocyte ferroptosis warrants investigation. We established an RSL3 (Ras-selective lethal 3)-induced ferroptosis model in primary human melanocytes and employed a multi-dimensional approach integrating transcriptomic profiling, network pharmacology, molecular docking, and immunofluorescence analysis. Clinical relevance was validated using lesional skin tissues from vitiligo patients. RSL3 challenge triggered canonical ferroptosis features, including lethal lipid peroxidation, glutathione depletion, and characteristic mitochondrial shrinkage, all of which were significantly attenuated by kaempferol. Mechanistically, unbiased transcriptomic and network analyses identified prostaglandin-endoperoxide synthase 2 (PTGS2) as a convergent node associated with both nuclear factor-κB (NF-κB)-driven inflammatory signaling and ferroptosis stress. We found that kaempferol markedly inhibited p65 nuclear translocation, accompanied by suppression of PTGS2 transcription. Notably, pharmacological inhibition of NF-κB using BAY 11-7082 phenocopied the anti-ferroptosis efficacy of kaempferol, supporting the functional involvement of this signaling axis. Furthermore, clinical analyses revealed aberrant activation of the NF-κB/PTGS2 pathway concomitant with ferroptosis signatures in vitiligo lesions. Our findings identify ferroptosis as a critical mechanism of melanocyte injury and delineate an NF-κB/PTGS2-associated signaling framework linking oxidative stress, inflammatory activation, and ferroptosis damage. By modulating this stress-responsive axis, kaempferol confers robust protection against ferroptosis melanocyte injury, highlighting its potential relevance as a ferroptosis-modulating strategy.
Insights
Kaempferol protects melanocytes from ferroptosis, a cell death mechanism implicated in vitiligo. This study identifies a key signaling pathway involving nuclear factor-κB (NF-κB) and prostaglandin-endoperoxide synthase 2 (PTGS2) that kaempferol modulates to prevent cell damage.
Area of Science:
- Dermatology
- Cell Biology
- Pharmacology
Background:
- Ferroptosis, a form of oxidative stress-induced cell death, contributes to melanocyte loss in vitiligo.
- The signaling pathways linking inflammation to ferroptosis in melanocytes are not fully understood.
- Kaempferol, a flavonoid from Vernonia anthelmintica, has antioxidant and anti-inflammatory properties, but its role in melanocyte ferroptosis is unexplored.
Purpose of the Study:
- To investigate the protective effects of kaempferol against ferroptosis in human melanocytes.
- To elucidate the molecular mechanisms underlying kaempferol's action, focusing on inflammatory signaling pathways.
- To validate the clinical relevance of identified pathways in vitiligo lesions.
Main Methods:
- Established a ferroptosis model in primary human melanocytes using RSL3 (Ras-selective lethal 3).
- Integrated transcriptomic profiling, network pharmacology, molecular docking, and immunofluorescence.
- Validated findings in lesional skin tissues from vitiligo patients.
Main Results:
- Kaempferol significantly attenuated RSL3-induced ferroptosis markers, including lipid peroxidation and mitochondrial damage.
- Transcriptomic analysis identified prostaglandin-endoperoxide synthase 2 (PTGS2) as a key node linking nuclear factor-κB (NF-κB) signaling to ferroptosis.
- Kaempferol inhibited NF-κB activation and subsequent PTGS2 transcription; NF-κB inhibition mimicked kaempferol's protective effects.
- The NF-κB/PTGS2 pathway and ferroptosis signatures were concurrently activated in vitiligo lesions.
Conclusions:
- Ferroptosis is a critical mechanism driving melanocyte injury in vitiligo.
- An NF-κB/PTGS2 signaling axis connects oxidative stress, inflammation, and ferroptosis.
- Kaempferol demonstrates potential as a therapeutic agent by modulating this pathway to protect melanocytes from ferroptosis.
Related Concept Videos
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
NF-kB-dependent Signaling Pathway
